Am J Epidemiol 2002; 156:1070-1077.
Copyright © 2002 by Johns
Hopkins Bloomberg School of Public Health
PRACTICE OF EPIDEMIOLOGY |
Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort Study
1 Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
2 Department of Physiology, University of Kuopio, Kuopio, Finland.
3 Research Institute of Public Health, University of Kuopio, Kuopio, Finland.
4 Department of Public Health and General Practice, University of Kuopio, Kuopio, Finland.
5 Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI.
6 Inner Savo Health Centre, Suonenjoki, Finland.
7 Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
The World Health Organization (WHO) and the National Cholesterol Education Program (NCEP) recently proposed definitions for the metabolic syndrome. Little is known of their validity, however. The authors assessed the sensitivity and specificity of the definitions of the metabolic syndrome for prevalent and incident diabetes mellitus in a Finnish population-based cohort of middle-aged men (n = 1,005) followed for 4 years since the late 1980s. Four definitions based on the WHO and NCEP recommendations were compared. All definitions identified persons at high risk for developing diabetes during the 4-year follow-up (odds ratios = 5.08.8). The WHO definition including waist-hip ratio > 0.90 or body mass index
30 kg/m2 was the most sensitive (0.83 and 0.67) and least specific (0.78 and 0.80) in detecting the 47 prevalent and 51 incident cases of diabetes. The NCEP definition in which adiposity was defined as waist girth > 102 cm detected only 61% of prevalent and 41% of incident diabetes, although it was the most specific (0.89 and 0.90). The WHO definition seems valid as judged by its relatively high sensitivity and specificity in predicting diabetes. The NCEP definition including waist > 102 cm also identifies persons at high risk for diabetes, but it is relatively insensitive in predicting diabetes.
diabetes mellitus; hyperinsulinism; hyperlipidemia; hypertension; insulin resistance; obesity
Abbreviations: Abbreviations: EGIR, European Group for the Study of Insulin Resistance; HDL, high density lipoprotein; NCEP, National Cholesterol Education Program; QUICKI, quantitative insulin sensitivity check index; WHO, World Health Organization.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel The Metabolic Syndrome Endocr. Rev., December 1, 2008; 29(7): 777 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Valtonen, D. E. Laaksonen, T. Tolmunen, K. Nyyssonen, H. Viinamaki, J. Kauhanen, and L. Niskanen Hopelessness -- novel facet of the metabolic syndrome in men Scand J Public Health, November 1, 2008; 36(8): 795 - 802. [Abstract] [PDF] |
||||
![]() |
K. L. Chichlowska, K. M. Rose, A. V. Diez-Roux, S. H. Golden, A. M. McNeill, and G. Heiss Individual and Neighborhood Socioeconomic Status Characteristics and Prevalence of Metabolic Syndrome: The Atherosclerosis Risk in Communities (ARIC) Study Psychosom Med, November 1, 2008; 70(9): 986 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
Studies to Treat or Prevent Pediatric Type 2 Diabe Prevalence of the Metabolic Syndrome Among a Racially/Ethnically Diverse Group of U.S. Eighth-Grade Adolescents and Associations With Fasting Insulin and Homeostasis Model Assessment of Insulin Resistance Levels Diabetes Care, October 1, 2008; 31(10): 2020 - 2025. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chinali, G. de Simone, M. J. Roman, L. G. Best, E. T. Lee, M. Russell, B. V. Howard, and R. B. Devereux Cardiac Markers of Pre-Clinical Disease in Adolescents With the Metabolic Syndrome: The Strong Heart Study J. Am. Coll. Cardiol., September 9, 2008; 52(11): 932 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Olufadi and C D Byrne Clinical and laboratory diagnosis of the metabolic syndrome J. Clin. Pathol., June 1, 2008; 61(6): 697 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kyrolainen, K. Hakkinen, H. Kautiainen, M. Santtila, K. Pihlainen, and A. Hakkinen Physical fitness, BMI and sickness absence in male military personnel Occup. Med., June 1, 2008; 58(4): 251 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hassinen, T. A. Lakka, K. Savonen, H. Litmanen, L. Kiviaho, D. E. Laaksonen, P. Komulainen, and R. Rauramaa Cardiorespiratory Fitness as a Feature of Metabolic Syndrome in Older Men and Women: The Dose-Responses to Exercise Training Study (DR's EXTRA) Diabetes Care, June 1, 2008; 31(6): 1242 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Despres, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose, J. Rodes-Cabau, O. F. Bertrand, and P. Poirier Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1039 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Lin, H.-K. Kuo, L.-P. Lai, J.-L. Lin, C.-D. Tseng, and J.-J. Hwang Inverse Correlation Between Heart Rate Recovery and Metabolic Risks in Healthy Children and Adolescents: Insight from the National Health and Nutrition Examination Survey 1999-2002 Diabetes Care, May 1, 2008; 31(5): 1015 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mattsson, T. Ronnemaa, M. Juonala, J. S.A. Viikari, E. Jokinen, N. Hutri-Kahonen, M. Kahonen, T. Laitinen, and O. T. Raitakari Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns Study Eur. Heart J., March 2, 2008; 29(6): 784 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J Kaaja Metabolic syndrome and the menopause Menopause Int, March 1, 2008; 14(1): 21 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lopez-Jimenez, F. H. Sert Kuniyoshi, A. Gami, and V. K. Somers Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease Chest, March 1, 2008; 133(3): 793 - 804. [Full Text] [PDF] |
||||
![]() |
G. Hu, J. Lindstrom, P. Jousilahti, M. Peltonen, L. Sjoberg, R. Kaaja, J. Sundvall, and J. Tuomilehto The Increasing Prevalence of Metabolic Syndrome among Finnish Men and Women over a Decade J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 832 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M.J. Wassink, Y. van der Graaf, J. K. Olijhoek, F. L.J. Visseren, and for the SMART Study Group Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm Eur. Heart J., January 2, 2008; 29(2): 213 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Qi, Z. Yu, X. Ye, F. Zhao, P. Huang, F. B. Hu, O. H. Franco, J. Wang, H. Li, Y. Liu, et al. Elevated Retinol-Binding Protein 4 Levels Are Associated with Metabolic Syndrome in Chinese People J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4827 - 4834. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rashidi, A. Ghanbarian, and F. Azizi Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 976 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Kim, S. M. Kim, J. S. Lee, H. J. Oh, J. H. Han, Y. Song, H. Joung, and H. S. Park Dietary Patterns and the Metabolic Syndrome in Korean Adolescents: 2001 Korean National Health and Nutrition Survey Diabetes Care, July 1, 2007; 30(7): 1904 - 1905. [Full Text] [PDF] |
||||
![]() |
B. M.Y. Cheung, N. M.S. Wat, Y. B. Man, S. Tam, G. N. Thomas, G. M. Leung, C. H. Cheng, J. Woo, E. D. Janus, C. P. Lau, et al. Development of Diabetes in Chinese With the Metabolic Syndrome: A 6-year prospective study Diabetes Care, June 1, 2007; 30(6): 1430 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vazquez, S. Duval, D. R. Jacobs Jr., and K. Silventoinen Comparison of Body Mass Index, Waist Circumference, and Waist/Hip Ratio in Predicting Incident Diabetes: A Meta-Analysis Epidemiol. Rev., May 10, 2007; (2007) mxm008v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kallio, M. Kolehmainen, D. E Laaksonen, J. Kekalainen, T. Salopuro, K. Sivenius, L. Pulkkinen, H. M Mykkanen, L. Niskanen, M. Uusitupa, et al. Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1417 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Q. Shaibi, M. L. Cruz, M. J. Weigensberg, C. M. Toledo-Corral, C. J. Lane, L. A. Kelly, J. N. Davis, C. Koebnick, E. E. Ventura, C. K. Roberts, et al. Adiponectin Independently Predicts Metabolic Syndrome in Overweight Latino Youth J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1809 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pambianco, T. Costacou, and T. J. Orchard The Prediction of Major Outcomes of Type 1 Diabetes: a 12-Year Prospective Evaluation of Three Separate Definitions of the Metabolic Syndrome and Their Components and Estimated Glucose Disposal Rate: The Pittsburgh Epidemiology of Diabetes Complications Study experience Diabetes Care, May 1, 2007; 30(5): 1248 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Kakafika, D. P. Mikhailidis, A. Karagiannis, and V. G. Athyros The Role of Endocannabinoid System Blockade in the Treatment of the Metabolic Syndrome J. Clin. Pharmacol., May 1, 2007; 47(5): 642 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Raikkonen, K. A. Matthews, and L. H. Kuller Depressive Symptoms and Stressful Life Events Predict Metabolic Syndrome Among Middle-Aged Women: A comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions Diabetes Care, April 1, 2007; 30(4): 872 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nisoli, E. Clementi, M. O. Carruba, and S. Moncada Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome? Circ. Res., March 30, 2007; 100(6): 795 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Auchincloss, A. V. Diez Roux, D. G. Brown, E. S. O'Meara, and T. E. Raghunathan Association of Insulin Resistance with Distance to Wealthy Areas: The Multi-Ethnic Study of Atherosclerosis Am. J. Epidemiol., February 15, 2007; 165(4): 389 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Friedlander, J. Weinreb, I. Friedlander, and J. A. Yagiela Metabolic syndrome: Pathogenesis, medical care and dental implications J Am Dent Assoc, February 1, 2007; 138(2): 179 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Nichols, T. A. Hillier, and J. B. Brown Progression From Newly Acquired Impaired Fasting Glusose to Type 2 Diabetes Diabetes Care, February 1, 2007; 30(2): 228 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ekelund, S. J. Griffin, N. J. Wareham, and on behalf of the ProActive Research Group Physical Activity and Metabolic Risk in Individuals With a Family History of Type 2 Diabetes Diabetes Care, February 1, 2007; 30(2): 337 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, S. Ma, D. Heng, C.-E. Tan, S.-K. Chew, K. Hughes, and E-S. Tai Should Central Obesity Be an Optional or Essential Component of the Metabolic Syndrome?: Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study Diabetes Care, February 1, 2007; 30(2): 343 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R Hajer, Y. van der Graaf, J. K Olijhoek, M. C Verhaar, F. L J Visseren, and for the SMART Study Group Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome Heart, February 1, 2007; 93(2): 216 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P Chung, I. Avalos, A. Oeser, T. Gebretsadik, A. Shintani, P. Raggi, and C Michael Stein High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors Ann Rheum Dis, February 1, 2007; 66(2): 208 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, E. S Ford, L. C McGuire, and A. H Mokdad Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey J Epidemiol Community Health, January 1, 2007; 61(1): 67 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Richelsen, S. Tonstad, S. Rossner, S. Toubro, L. Niskanen, S. Madsbad, P. Mustajoki, and A. Rissanen Effect of Orlistat on Weight Regain and Cardiovascular Risk Factors Following a Very-Low-Energy Diet in Abdominally Obese Patients: A 3-year randomized, placebo-controlled study Diabetes Care, January 1, 2007; 30(1): 27 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cirillo, W. Sato, S. Reungjui, M. Heinig, M. Gersch, Y. Sautin, T. Nakagawa, and R. J. Johnson Uric Acid, the Metabolic Syndrome, and Renal Disease J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S165 - S168. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Buresova, V. Zidek, A. Musilova, M. Simakova, A. Fucikova, V. Bila, V. Kren, L. Kazdova, R. Di Nicolantonio, and M. Pravenec Genetic relationship between placental and fetal weights and markers of the metabolic syndrome in rat recombinant inbred strains Physiol Genomics, September 14, 2006; 26(3): 226 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Unwin The metabolic syndrome J R Soc Med, September 1, 2006; 99(9): 457 - 462. [Full Text] [PDF] |
||||
![]() |
B. Ovbiagele, J. L. Saver, M. J. Lynn, M. Chimowitz, and for the WASID Study Group Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis Neurology, May 9, 2006; 66(9): 1344 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Bernstein, J. Berry, S. Kim, B. Canavan, and S. K. Grinspoon Effects of Etanercept in Patients With the Metabolic Syndrome. Arch Intern Med, April 24, 2006; 166(8): 902 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Desvergne, L. Michalik, and W. Wahli Transcriptional Regulation of Metabolism Physiol Rev, April 1, 2006; 86(2): 465 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I Brixner, Q. Said, P. K Corey-Lisle, A V. Tuomari, G. J L'Italien, W. Stockdale, and G. M Oderda Naturalistic Impact of Second-Generation Antipsychotics on Weight Gain Ann. Pharmacother., April 1, 2006; 40(4): 626 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Grundy Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1093 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dallongeville, M.-C. Grupposo, D. Cottel, J. Ferrieres, D. Arveiler, A. Bingham, J.-B. Ruidavets, B. Haas, P. Ducimetiere, and P. Amouyel Association between the metabolic syndrome and parental history of premature cardiovascular disease Eur. Heart J., March 2, 2006; 27(6): 722 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C Deedwania and R. Schmieder Angiotensin Receptor Blockers: Cardiovascular Protection in the Metabolic Syndrome Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1_suppl): S12 - S18. [Abstract] [PDF] |
||||
![]() |
P. T. Katzmarzyk, I. Janssen, R. Ross, T. S. Church, and S. N. Blair The Importance of Waist Circumference in the Definition of Metabolic Syndrome: Prospective analyses of mortality in men Diabetes Care, February 1, 2006; 29(2): 404 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fallo, F. Veglio, C. Bertello, N. Sonino, P. Della Mea, M. Ermani, F. Rabbia, G. Federspil, and P. Mulatero Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 454 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Najarian, L. M. Sullivan, W. B. Kannel, P. W. F. Wilson, R. B. D'Agostino, and P. A. Wolf Metabolic Syndrome Compared With Type 2 Diabetes Mellitus as a Risk Factor for Stroke: The Framingham Offspring Study Arch Intern Med, January 9, 2006; 166(1): 106 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pladevall, B. Singal, L. K. Williams, C. Brotons, H. Guyer, J. Sadurni, C. Falces, M. Serrano-Rios, R. Gabriel, J. E. Shaw, et al. A Single Factor Underlies the Metabolic Syndrome: A confirmatory factor analysis Diabetes Care, January 1, 2006; 29(1): 113 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Eberly, R. Prineas, J. D. Cohen, G. Vazquez, X. Zhi, J. D. Neaton, L. H. Kuller, and for the Multiple Risk Factor Intervention Trial Re Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial Diabetes Care, January 1, 2006; 29(1): 123 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.G. Hanley, A. J. Karter, K. Williams, A. Festa, R. B. D'Agostino Jr, L. E. Wagenknecht, and S. M. Haffner Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study Circulation, December 13, 2005; 112(24): 3713 - 3721. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Wannamethee, A. G. Shaper, L. Lennon, and R. W. Morris Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus Arch Intern Med, December 12, 2005; 165(22): 2644 - 2650. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E Laaksonen, L. K Toppinen, K. S Juntunen, K. Autio, K.-H. Liukkonen, K. S Poutanen, L. Niskanen, and H. M Mykkanen Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1218 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Y. Tong, C.-S. Ho, V. T. F. Yeung, M. C. Y. Ng, W.-Y. So, R. Ozaki, G. T. C. Ko, R. C. W. Ma, E. Poon, N. N. Chan, et al. Association of Testosterone, Insulin-Like Growth Factor-I, and C-Reactive Protein with Metabolic Syndrome in Chinese Middle-Aged Men with a Family History of Type 2 Diabetes J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6418 - 6423. [Abstract] [Full Text] [PDF] |
||||
![]() |
Prepared by: British Cardiac Society, British Hype JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart, December 1, 2005; 91(suppl_5): v1 - v52. [Full Text] [PDF] |
||||
![]() |
|






























